| Product Code: ETC11902446 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Pharmaceutical Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Pharmaceutical Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Pharmaceutical Market - Industry Life Cycle |
3.4 Ireland Pharmaceutical Market - Porter's Five Forces |
3.5 Ireland Pharmaceutical Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Ireland Pharmaceutical Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.7 Ireland Pharmaceutical Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.8 Ireland Pharmaceutical Market Revenues & Volume Share, By Formulation, 2021 & 2031F |
3.9 Ireland Pharmaceutical Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Ireland Pharmaceutical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing healthcare expenditure in Ireland |
4.2.2 Growth in the aging population leading to higher demand for pharmaceutical products |
4.2.3 Rise in prevalence of chronic diseases requiring long-term medication |
4.3 Market Restraints |
4.3.1 Stringent regulatory environment impacting product approvals and market access |
4.3.2 Pricing pressures and cost containment measures affecting profit margins of pharmaceutical companies |
5 Ireland Pharmaceutical Market Trends |
6 Ireland Pharmaceutical Market, By Types |
6.1 Ireland Pharmaceutical Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Pharmaceutical Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 Ireland Pharmaceutical Market Revenues & Volume, By Branded Drugs, 2021 - 2031F |
6.1.4 Ireland Pharmaceutical Market Revenues & Volume, By Generic Drugs, 2021 - 2031F |
6.1.5 Ireland Pharmaceutical Market Revenues & Volume, By OTC Drugs, 2021 - 2031F |
6.1.6 Ireland Pharmaceutical Market Revenues & Volume, By Biologics, 2021 - 2031F |
6.2 Ireland Pharmaceutical Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Ireland Pharmaceutical Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.2.3 Ireland Pharmaceutical Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.2.4 Ireland Pharmaceutical Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.2.5 Ireland Pharmaceutical Market Revenues & Volume, By Direct Sales, 2021 - 2031F |
6.3 Ireland Pharmaceutical Market, By Therapeutic Area |
6.3.1 Overview and Analysis |
6.3.2 Ireland Pharmaceutical Market Revenues & Volume, By Cardiovascular, 2021 - 2031F |
6.3.3 Ireland Pharmaceutical Market Revenues & Volume, By Oncology, 2021 - 2031F |
6.3.4 Ireland Pharmaceutical Market Revenues & Volume, By Neurology, 2021 - 2031F |
6.3.5 Ireland Pharmaceutical Market Revenues & Volume, By Dermatology, 2021 - 2031F |
6.4 Ireland Pharmaceutical Market, By Formulation |
6.4.1 Overview and Analysis |
6.4.2 Ireland Pharmaceutical Market Revenues & Volume, By Tablet, 2021 - 2031F |
6.4.3 Ireland Pharmaceutical Market Revenues & Volume, By Capsule, 2021 - 2031F |
6.4.4 Ireland Pharmaceutical Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.4.5 Ireland Pharmaceutical Market Revenues & Volume, By Liquid, 2021 - 2031F |
6.5 Ireland Pharmaceutical Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Ireland Pharmaceutical Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.5.3 Ireland Pharmaceutical Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.5.4 Ireland Pharmaceutical Market Revenues & Volume, By Pharmacies, 2021 - 2031F |
6.5.5 Ireland Pharmaceutical Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
7 Ireland Pharmaceutical Market Import-Export Trade Statistics |
7.1 Ireland Pharmaceutical Market Export to Major Countries |
7.2 Ireland Pharmaceutical Market Imports from Major Countries |
8 Ireland Pharmaceutical Market Key Performance Indicators |
8.1 Research and development investment in innovative therapies |
8.2 Number of clinical trials conducted in Ireland |
8.3 Adoption rate of digital health technologies in healthcare facilities |
8.4 Government initiatives promoting local pharmaceutical manufacturing |
8.5 Percentage of pharmacists trained in specialized pharmaceutical services |
9 Ireland Pharmaceutical Market - Opportunity Assessment |
9.1 Ireland Pharmaceutical Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Ireland Pharmaceutical Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.3 Ireland Pharmaceutical Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.4 Ireland Pharmaceutical Market Opportunity Assessment, By Formulation, 2021 & 2031F |
9.5 Ireland Pharmaceutical Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Ireland Pharmaceutical Market - Competitive Landscape |
10.1 Ireland Pharmaceutical Market Revenue Share, By Companies, 2024 |
10.2 Ireland Pharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here